Keywords: Abbott Labs, Johnson & Johnson, CentororOrtho, Humira, Remicade, Patent, USA, Court of Appeals

Abbott prevails as US Court of Appeals overturns $1.8 billion patent verdict for J&J unit

Article | 24 February 2011

Print This

There was bad news for Centocor Ortho Biotech, a Johnson & Johnson (NYSE: JNJ) company, yesterday, after it received a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in